The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across ...

SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

Safely publish packages, store your packages alongside your code, and share your packages privately with your team.

We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Maintaining independence and editorial freedom is essential to ...

Insilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Republican Vivek Ramaswamy is preparing to launch his 2026 bid for Ohio governor on Feb. 24 in his native Cincinnati, with ...

As climate change looms over us all, many industries are turning to biotechnology for solutions to make all aspects of our lives more sustainable for the environment. Biotechnology is uniquely ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...